Virta Health, a company using nutritional therapy to reverse type 2 diabetes and metabolic disease, now publishing data on GLP-1 discontinuation, liver disease, and even oncology outcomes.

“We can reverse that kind of state of type 2 diabetes in 6 to9 months and then sustain it for long term. 13% average body weight loss.”

Virta Health patients who discontinue GLP-1 drugs sustain weight loss with no regain at 18 months, per published peer-reviewed data.

“We've been able to sustain that weight loss. This is published and peer review data 18 months out and soon we will have even longerterm data, but 18 months no weight regain.”

Virta Health's nutritional therapy reverses type 2 diabetes in 6 to 9 months with 13% average body weight loss in an intent-to-treat analysis.

“We can reverse that kind of state of type 2 diabetes in 6 to9 months and then sustain it for long term. 13% average body weight loss.”

Virta Health produces identical outcomes across all socioeconomic strata as measured by Area Deprivation Index, across all zip codes in America.

“We've analyzed outcomes based on what's called ADI, so area deprivation index. So you take all zip codes in America and you rank them by average income and exactly the same outcomes, exactly the same outcomes.”

Type 2 diabetes is fundamentally reversible, contradicting the mainstream clinical framing of it as a chronic and progressive disease.

“That disease among with other metabolic health conditions is fundamentally reversible.”

Virta Health's nutritional therapy shows up to 75% reduction in liver disease (MASH/MAFLD).

“We've been able to show up to 75% reduction in liver disease.”

Virta Health patient adherence at one year is twice as high as adherence to GLP-1 drugs.

“The adherence of verta patients again which are like real Americans not sis real Americans is twice as high at one year as taking a JB1 drug.”

80% of Virta Health patients on GLP-1s report wanting to severely reduce or eliminate dependence on those drugs.

“80% of them say I either want to severely reduce the dependence on these drugs or get completely awful.”

Adding Virta Health's nutritional therapy to standard chemotherapy for stage 4 metastatic pancreatic cancer produced approximately 35% average life extension.

“We were able to show just about 35% life extension on average in that arm.”